2023

The symposium also marks a change in IASLC leadership as Dr. Heather Wakelee will deliver the final Presidential Address of her term.

IASLC Staging and Prognostic Factors Committee Chair Dr. Hisao Asamura joins Drs. Valerie Rusch and Enrico Ruffini to review updates in lung cancer, mesothelioma, and thymic cancer.

The IASLC Cancer Care Team award highlights the teamwork required to provide the best possible patient care.

Since WCLC 2022, JTO, led by Dr. Alex A. Adjei, has continued to increase its impact factor, and JTO CRR has welcomed a new Editor-in-Chief, Dr. Emily Stone.

In an exclusive interview, Princess Dina talks with ILCN about her passion for improving equitable access to cancer care, tobacco control, prevention, and more.

Dr. Narjust Florez, who helped bring the session to fruition, will join other successful women in lung cancer as well as Her Royal Highness Princess Dina Mired of Jordan to discuss experiences, concerns, and solutions.

On Sunday eight investigators—including Dr. Anne-Marie Baird and the Go2 Foundation’s Brittney Nichols, MPH—will present research on global challenges in lung cancer care during the “Barriers and Benefits” mini oral abstract session.

In an interview with ILCN, Dr. Paul Van Schil discusses his goals of further strengthening the international character of the association and encouraging more scientific contribution, particularly from smaller specialties.

Monday afternoon, Drs. Anne Tsao and Maria Ftanou will offer institutional- and individual-level strategies to help healthcare providers take better care of themselves so they can continue to care for patients.

Sunday morning, hear nine state-of-the-art lectures spanning multiple specialties when the 2023 award winners take the stage during Plenary 2.